Search results

Results 1 – 11 of 11
Advanced search

Search in namespaces:

There is a page named "PIK3CA-related overgrowth spectrum" on Wikipedia

  • PIK3CA-related overgrowth spectrum (PROS) is an umbrella term for rare syndromes characterized by malformations and tissue overgrowth caused by somatic...
    5 KB (487 words) - 20:17, 23 February 2022
  • Thumbnail for Facial infiltrating lipomatosis
    craniofacial overgrowth condition caused by a genetic mutation of the PIK3CA gene. The condition is a part of the PIK3CA related overgrowth spectrum (PROS)...
    7 KB (781 words) - 15:29, 3 February 2022
  • Thumbnail for Proteus syndrome
    syndrome, but rather the often-misdiagnosed PIK3CA-related overgrowth spectrum, a syndrome caused by a PIK3CA gene mutation.[citation needed] Epidermal...
    18 KB (1,926 words) - 15:43, 19 May 2024
  • Thumbnail for P110α
    P110α (redirect from PIK3CA)
    Phosphoinositide 3-kinase Phosphoinositide 3-kinase inhibitor PIK3CA-related overgrowth spectrum P110α has been shown to interact with: ARHGEF1, ADAP1, DGKZ...
    17 KB (1,929 words) - 02:08, 3 December 2023
  • Thumbnail for Beckwith–Wiedemann syndrome
    Beckwith–Wiedemann syndrome (/ˈbɛkˌwɪθ ˈviːdə.mən/; abbreviated BWS) is an overgrowth disorder usually present at birth, characterized by an increased risk...
    31 KB (3,949 words) - 17:49, 23 January 2024
  • Thumbnail for Alpelisib
    the US to include the treatment of severe manifestations of PIK3CA-related overgrowth spectrum (PROS) in those who require systemic therapy. In May 2019...
    15 KB (958 words) - 05:40, 18 July 2024
  • Partido Republicano da Ordem Social PROS (PIK3CA-related overgrowth spectrum), a form of tissue overgrowth Pro (disambiguation) This disambiguation page...
    439 bytes (80 words) - 11:49, 3 October 2018
  • Thumbnail for CLOVES syndrome
    mosaic gain-of-function mutations of the PIK3CA gene, and belongs to the spectrum of PIK3CA-related overgrowth syndromes (PROS). This rare condition has...
    7 KB (712 words) - 07:47, 13 October 2023
  • grants Breakthrough Therapy Designation for Roche's balovaptan in autism spectrum disorder". Roche. Retrieved 2024-04-08. "Approval report" (PDF). U.S. Food...
    34 KB (180 words) - 22:09, 8 April 2024
  • Thumbnail for Megalencephaly
    novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes". Nat Genet. 44 (8): 934–40. doi:10...
    23 KB (2,503 words) - 23:16, 30 June 2024
  • Thumbnail for Macrocephaly-capillary malformation
    and low muscle tone. Mosaic mutations in PIK3CA have been found to be the genetic cause of M-CM. Other overgrowth conditions with distinct phenotypes have...
    18 KB (1,678 words) - 07:11, 15 April 2024